Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

著者: Marı́a Buti, Edward Gane, Wai Kay Seto, Henry Lik‐Yuen Chan, Wan‐Long Chuang, T. E. Stepanova, Aric-Josun Hui, Young‐Suk Lim, Rajiv Mehta, Harry L.A. Janssen, Subrat Kumar Acharya, John F. Flaherty, Benedetta Massetto, Andrea L. Cathcart, Kyungpil Kim, Anuj Gaggar, G. Mani Subramanian, John G. McHutchison, Calvin Q. Pan, Maurizia Rossana Brunetto, Namiki Izumi, Patrick Marcellin - The Lancet 2016 被引用: 546